A fetal echocardiogram is not a routine test for every pregnancy. It’s a specialized ultrasound of the baby’s heart, recommended when something in your pregnancy history, family background, or earlier screening results puts your baby at higher-than-average risk for a congenital heart defect. For low-risk pregnancies, the standard anatomy scan around 18 to 22 weeks includes a basic look at the heart’s structure, and that’s typically enough.
The question of whether you specifically need one depends on a short list of well-defined risk factors. Here’s what makes the difference.
Who Actually Needs a Fetal Echo
Doctors recommend a fetal echocardiogram when the chance of a heart defect is meaningfully higher than the general population’s baseline risk, which sits just under 1%. The most common reasons fall into three categories: something about your health, something about your family history, or something flagged during a routine scan.
On the maternal side, diabetes is one of the strongest triggers. Both pregestational diabetes (type 1 or type 2 that existed before pregnancy) and gestational diabetes are associated with changes in fetal heart structure and function, including thickening of the heart muscle, problems with how the heart relaxes between beats, and overall reduced heart performance. Current practice calls for detailed cardiac evaluation in all pregnancies complicated by pregestational diabetes. Some providers also recommend it for gestational diabetes, particularly when blood sugar has been poorly controlled.
IVF conception is another established indication. The baseline risk of a congenital heart defect roughly doubles with IVF, rising from just under 1% to about 2%. For IVF twins, it climbs above 2%. That jump is enough to qualify for screening. Other maternal factors that can prompt a referral include certain medications taken early in pregnancy (particularly some anti-seizure drugs and acne treatments), autoimmune conditions, and infections during the first trimester.
Family History and Recurrence Risk
If a first-degree relative has a congenital heart defect, the math shifts substantially. When one previous child was born with a heart defect, the recurrence risk in a future pregnancy is about 3.5%. If two previous children were affected, that rises to roughly 4.5%. The numbers are even higher when a parent carries the condition: 5.2% when the mother has a heart defect, and 7.5% when the father does. Even a single second- or third-degree relative (a sibling’s child, an aunt or uncle) with a heart defect raises recurrence to about 3.5%.
These percentages may sound small in absolute terms, but they represent a three- to sevenfold increase over the general population. That’s why family history alone is enough to warrant a fetal echo, even when everything else in the pregnancy looks normal.
When a Routine Scan Raises a Flag
Sometimes the need for a fetal echo only becomes apparent partway through pregnancy. One of the most common triggers is an elevated nuchal translucency measurement, taken during a first-trimester screening between 11 and 14 weeks. This measurement looks at the fluid-filled space at the back of the baby’s neck. The American College of Obstetricians and Gynecologists recommends a fetal echocardiogram whenever that measurement reaches 3.5 mm or higher. Any value above the 99th percentile calls for closer cardiovascular evaluation by a fetal cardiologist.
Other findings that can prompt a referral include an irregular fetal heart rhythm detected during a routine visit, a suspected structural abnormality on the anatomy scan, certain chromosomal findings from genetic screening, or too much or too little amniotic fluid.
What It Can and Cannot Detect
A fetal echocardiogram is highly reliable when it identifies a problem. Its specificity, the ability to correctly confirm a normal heart, is about 99.8%. But its sensitivity, the ability to catch defects that are actually there, is lower than many people expect: pooled data across studies puts it around 68.5%. That means roughly one in three heart defects can be missed, particularly smaller holes between chambers or subtle valve abnormalities.
Certain serious conditions are harder to catch than others. Detection rates below 50% have been reported for transposition of the great arteries, a critical defect where the two main vessels leaving the heart are swapped. Detection rates have been improving over time as imaging technology and training advance, but no prenatal test catches everything. Factors like maternal body composition, fetal position, and the experience of the person performing the scan all affect accuracy.
Why Early Detection Matters
For serious heart defects, knowing before birth changes what happens in the delivery room. When a critical condition like transposition of the great arteries or hypoplastic left heart syndrome is diagnosed prenatally, the birth can be planned at a hospital with a pediatric cardiac surgery team standing by. That head start translates into real differences: babies diagnosed before birth are less likely to need emergency surgery, mechanical ventilation, or antibiotics in the first days of life. They arrive at their first procedure in better condition overall, with fewer major pre-operative risk factors.
The benefits extend beyond the immediate newborn period. Research on hypoplastic left heart syndrome has shown that babies diagnosed prenatally experience fewer adverse neurological events around the time of surgery compared to those diagnosed after birth. In one study following children to age five, those with a prenatal diagnosis performed better on tests of executive function, the mental skills involved in planning, focus, and problem-solving. The likely explanation is that prenatal diagnosis prevents the prolonged oxygen deprivation that can occur when a critical heart defect goes unrecognized in the hours or days after birth.
A meta-analysis of 13 studies found that prenatal diagnosis consistently accelerated the timing of intervention for major heart defects, though a clear reduction in surgical mortality was only demonstrated for transposition of the great arteries. For other defects, the survival benefit has been harder to prove at a population level, even though the logic of earlier, better-planned care is straightforward. One reason is that prenatally diagnosed cases tend to be more severe on average (milder defects are more likely to be missed), which skews the comparison.
When It’s Typically Done
The standard window for a fetal echocardiogram is 18 to 24 weeks of pregnancy. At this stage, the heart is large enough to image in detail but early enough to allow time for planning if something is found. For high-risk pregnancies, some centers offer an early look between 12 and 14 weeks using high-frequency transvaginal or abdominal probes. Research has shown that cardiac evaluation at 13 weeks can perform comparably to scans at 18 weeks when color Doppler is used. Still, second-trimester scanning remains the gold standard because the heart’s structures are simply easier to see at that size.
An early scan does offer one important advantage: time. Parents who receive a diagnosis at 13 weeks have more room to pursue additional genetic testing, consult with specialists, and make informed decisions about their pregnancy and delivery plan.
If None of These Apply to You
For pregnancies without any of the risk factors above, the four-chamber heart view and outflow tract assessment included in a standard anatomy ultrasound is the recommended level of screening. A dedicated fetal echocardiogram in a low-risk pregnancy adds very little diagnostic value because the baseline rate of heart defects is low, and the test’s sensitivity means it would still miss a meaningful fraction of problems while generating anxiety and follow-up visits for borderline findings. The test is most powerful when it’s targeted at pregnancies where the prior probability of a defect is already elevated.